Standout Papers

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Res... 2007 2026 2013 2019 1.7k
  1. Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer (2007)
    Helmut Oettle, Stefan Post et al. JAMA

Immediate Impact

2 by Nobel laureates 18 from Science/Nature 111 standout
Sub-graph 1 of 19

Citing Papers

Sulfenylnitrene-mediated nitrogen-atom insertion for late-stage skeletal editing of N -heterocycles
2025 StandoutScience
Pancreatic Cancer
2021 Standout
11 intermediate papers

Works of E. Kettner being referenced

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Erlotinib as 2nd and 3rd line monotherapy in patients with metastatic colorectal cancer. Results of a multicenter two-cohort phase II trial
2005

Author Peers

Author Last Decade Papers Cites
E. Kettner 2584 1001 637 875 38 3.0k
P. Murawa 2960 1140 1063 756 48 4.1k
J. Mezger 1870 1655 344 527 53 3.3k
Elizabeth Poplin 2169 1183 480 712 79 3.1k
Jean–Luc Van Laethem 3038 1423 609 798 47 3.7k
H. Au 2869 1045 964 477 23 3.4k
A. Hennipman 1566 871 496 743 39 2.5k
Simon Pernot 2156 1031 595 520 97 3.4k
Richard G. Hahn 1997 779 455 648 65 3.4k
O. Kisker 2009 858 614 544 43 3.3k
Pascal Artru 3002 1414 962 834 131 3.6k

All Works

Loading papers...

Rankless by CCL
2026